A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

NCT00212797 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression
Depressive Disorders
Psychotic Disorders

Interventions

DRUG: Org 34517
DRUG: Org 34517
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC